Understanding lung cancer differences among various racial and ethnic groups
Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate risk
['FUNDING_R01'] · UNIVERSITY OF HAWAII AT MANOA · NIH-10755626
This study looks at how lung cancer affects different racial and ethnic groups to find out why some people are more at risk than others, and it hopes to use this information to help create better prevention and treatment options for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF HAWAII AT MANOA (nih funded) |
| Locations | 1 site (HONOLULU, UNITED STATES) |
| Trial ID | NIH-10755626 on ClinicalTrials.gov |
What this research studies
This research investigates the molecular characteristics of lung cancers across five different racial and ethnic groups to understand why certain populations are at higher or lower risk for the disease. It examines factors such as smoking history, lifestyle, and biological responses to tobacco carcinogens. By analyzing tumor biology and gene expression profiles, the study aims to uncover the underlying mechanisms contributing to disparities in lung cancer risk and outcomes. Patients may benefit from insights that could lead to more personalized prevention and treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse racial and ethnic backgrounds who have been diagnosed with lung cancer.
Not a fit: Patients who do not have lung cancer or those from racial/ethnic groups not included in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for lung cancer tailored to specific racial and ethnic groups.
How similar studies have performed: Previous studies have shown success in identifying racial and ethnic disparities in lung cancer risk, but this comprehensive molecular profiling approach is relatively novel.
Where this research is happening
HONOLULU, UNITED STATES
- UNIVERSITY OF HAWAII AT MANOA — HONOLULU, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARK, SUNGSHIM LANI — UNIVERSITY OF HAWAII AT MANOA
- Study coordinator: PARK, SUNGSHIM LANI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, Cancer Causing Agents